Trademark Search  /  SILANES

SILANES

○ Dead · Cancelled

U.S. federal trademark · Serial No. 85632415 · Reg. No. 1282768

Mark
SILANES
Status
Cancelled
Serial Number
85632415
Registration No.
1282768
Filing Date
November 22, 2011
Registration Date
April 30, 2012
Class(es)
Class 005

Owners

Laboratorios Silanes S.A. DE C.V.
03 · Mexico DF, MX
Laboratorios Silanes S.A. DE C.V.
03 · Mexico DF, MX
Laboratorios Silanes S.A. DE C.V.
03 · Mexico DF, MX

Goods & Services

Pharmaceuticals, namely, injectable solutions, tablets, pills and capsules for adults and children, oral suspensions, medicated syrups and ointments, all for treatment as a cough suppressant, and expectorant, having activity against anaerobic bacteria, trichomona vaginalis, entamoeba histolytica, and giardia lamblia, as an antifungal agent for treatment of oropharyngeal and esophageal candidiasis, candidal urinary tract infections, peritonitis and systemic candidal infections, candidemia, disseminated candidiasis and pneumonia, cryptococcal meningitis, candidal genital tract infections, as an analgesis anti-inflamatory non steroidal inhibitor of prostaglandin synthetase, analgesic and minor tranquilizer, active immunization against tetanus, peripheral neuritis, neuralgias, peripheral neuritis, neuralgias and haematopoietics, antifungal agents for treatment of systemic blastomycosis, histoplasmosis paracoccidloidomycosis, fungal infection of the gastrointestinal tract and tinea infections of the skin and nails, sulphonylurea and biguanide, hipoglycaemic agent, activity against trichomonas vaginalis, entamoeba histolytica and giardia lamblia, anaerobic bacteria, histamine h1-receptor antagonist and prophylactic treatment of asthma, and treatment of allergic conditions such as rhinitis and conjunctivitis, analgesic, anti-inflamatory non steroidal, for inhibiting prostaglandin synthetase, analgesic, anti-inflammatory non steroidal, inhibitor of prostaglandin synthetase and muscle relaxant, analgesic, antipyretic, sulphonylurea hipoglycaemic agent, for inhibiting as an angiotensin-converting enzyme, treatment of congestive heart failure and asymptomatic left ventricular dysfunction, diuretic treatment of congestive heart failure, hypertension, cardiac, renal hepatogenic oedema, peripheral neuritis, neuralgias and analgesic, a broad spectrum antibiotic, effective against a wide range of gram positive and gram negative aerobic and anaerobic bacterias, histamine h2-receptor antagonist in the treatment of gastric and duodenal ulcer, zollinger-ellison syndrome, for iron deficiency and anemia for children or adults, anixolytic , anticonvulsant, sedative, muscle relaxant, histamine h2-receptor antagonist in the treatment of gastric and duodenal ulcer zollinger-ellison syndrome, multivitamin treatment and prevention of vitamin b1-b6-b12 deficiency, tricyclic antidepressant, treatment of nocturnal enuresis in children, inhibition of angiotensin-converting enzyme, treatment of hypertension and congestive heart failure, treatment and prevention of vitamin C deficiency, treatment and prevention of seborrhea and dandruff, and as an analgesic not narcotic

Thinking of using a similar name?
Search 14 million+ trademarks free and see if your brand conflicts with "SILANES" or anything like it, before you file.
Run a free trademark search →

Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.